Filing Details

Accession Number:
0000711377-12-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-21 13:00:00
Reporting Period:
2012-05-18
Filing Date:
2012-05-21
Accepted Time:
2012-05-21 18:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-18 9,469 $13.55 118,990 No 4 M Direct
Coommon Stock Disposition 2012-05-18 9,469 $38.89 109,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2012-05-18 6,652 $0.00 6,652 $13.55
Common Stock Common Stock (Right to Buy) Disposition 2012-05-18 2,817 $0.00 2,817 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,857 No 4 M Direct
90,040 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,012 Indirect Held in trust by Neogen 401k plan
Footnotes
  1. Theses options were granted 8/9/2007 as ISO options, became exercisable in equal annual installments over a five year period,and expire on 8/9/2012
  2. These options were granted 8/9/2007 as NQ options, became exercisable in equal annual installments over a five year period, and expire on 8/9/2012